IBM opened at $232.74 on Wednesday, up 1.7%, as the company announced a key step forward in its quantum computing roadmap.
International Business Machines Corporation, IBM
The company said it successfully integrated and cooled the first two modules of its new cryogenic architecture. This is the infrastructure needed to link hundreds of quantum chips together in a shared ultra-cold environment.
The milestone moves IBM closer to launching Starling, a fault-tolerant quantum supercomputer it aims to release before 2030.
Fault tolerance means a system keeps working even when individual parts fail. For quantum computers, which rely on fragile subatomic states, this has been one of the hardest problems to solve.
“When we talk about Starling, we’re talking about a machine that’s at the scale of 200 qubits and 100 billion operations,” said Jerry Chow, IBM’s head of quantum-centric supercomputing.
The new architecture allows information to move between chips, enabling more complex calculations. The modules stand more than 8 feet tall and 8 feet wide and are already live at a facility in upstate New York.
Initial tests show the modules cool to 4 Kelvin in under five days and reach below 15 millikelvin shortly after. That level of cold, near absolute zero, is required for quantum processors to function.
This news comes weeks after IBM and research partners published three technical papers on how quantum calculations can be verified for accuracy in real time.
On the analyst side, several firms have trimmed their price targets recently. Argus cut its target from $360 to $280, JPMorgan dropped from $291 to $250, and Jefferies moved from $320 to $260. Susquehanna lowered its target to $225 with a neutral rating.
Of 27 analysts covering the stock, 15 have a Buy rating, 11 Hold, and one Sell. The average price target sits at $265.40, well above the current trading price.
IBM’s one-year trading range runs from $199.19 to $332.46, with its 50-day moving average at $249.44.
Merit Financial Group increased its IBM position by 6.6% in Q2, bringing its holdings to 55,171 units, valued at approximately $15.5 million.
Several other firms also added new positions during recent quarters, including Basepoint Wealth, Portus Wealth Advisors, and Joseph Group Capital Management. Overall, 58.96% of IBM stock is held by institutional investors.
IBM reported Q2 earnings of $2.93 per share, matching analyst estimates. Revenue came in at $17.16 billion, slightly below the $17.46 billion consensus. That was up 1.1% year over year.
A quarterly dividend of $1.69 per share will be paid on September 10, representing an annualized yield of 2.9%.
IBM also faces a securities fraud investigation related to its Z mainframe slowdown, announced by law firm Bleichmar Fonti and Auld. No wrongdoing has been established.
Starling is set to serve as a bridge to Blue Jay, an even more powerful machine IBM plans to release in the early 2030s.
The post Is IBM Stock Worth Buying After Its Quantum Computing Breakthrough? appeared first on CoinCentral.
